Industry

Nutrigenomics: from Biofarma an innovative approach to cardiometabolic diseases

Biofarma Group has consolidated its expertise in the formulation of dietary supplements aimed at cardiometabolic well-being.

New era in infant nutrition: Lallemand Health Solutions and DSM-Firmenich formulate synbiotic solutions

Isabelle Champié: “At Lallemand Health Solutions, we are committed to pushing the boundaries of probiotic research and development to create solutions that promote optimal health and well-being.

Flow cytometry: from Biofarma Group, a new approach for probiotic counting

A team of researchers have carried out a study on the search for bacterial probiotics, using a new method: flow cytometry

Advanced long-read sequencing services revolutionize microbiome analysis

Clinical Microbiomics sets a new standard in microbial research with unmatched data precision and resolution.

Sacco System unveils new biotech development site in Brisbane

Sacco System announces the grand opening of its development site in Australia.

Tailoring pet health: Nestlé’s new kit personalizes nutrition based on pet microbiome analysis

The new kit is part of the 'Petivity by Purina Petcare' ecosystem, which uses advanced tools to improve pet health and longevity through enhanced nutritional science.

Consumer behavior in probiotic consumption

MicrobiomePost carried out a research analysis in collaboration with Analytics Arts to find out more about the motivations and frequency of probiotic consumption and the level of consumer information.

MaaT Pharma demonstrates significant survival benefits with MaaT013 in Acute Graft-Versus-Host Disease

These findings underscore MaaT013's potential as a third-line treatment option, where traditional treatments often fall short.

Revolutionizing skin health: advanced probiotic-oil suspension to transform microbial balance in seborrheic dermatitis

Researchers at the San Gallicano Dermatological Institute in Rome, Italy, conducted an open-label exploratory trial to assess the therapeutic potential of EUTOPLAC, a topical probiotic containing Lactobacillus crispatus P 17631…

EnteroBiotix embarks on groundbreaking phase 2 trial for innovative IBS treatment

Launching a new frontier in IBS management: the 'TrIuMPH' trial sets the stage with EBX-102-02, a pioneer in microbiome-based therapy.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top